Millennium Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Millennium Management’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200,000	Closed	-$1.2M	–	7465
2022 Q4	$1.2M	Buy	+200,000	New	+$1.09M	﹤0.01%	3985

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Millennium Management's CTIC Position: Q2 2023 in Review

Millennium Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 866,152 shares — an estimated $3.64M sold.

Millennium Management first reported a position in CTIC in Q2 2013 and held it in 30 quarters. The position peaked at $28.6M in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Millennium Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 866,152 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $3.64M.
Millennium Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 30 quarters.
Millennium Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $28.6M in Q4 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.